Brief: AC Immune Q2 Operating Income CHF -19.388 Million
05/08/2025 12:00
Aug 05 (Reuters) - AC Immune Q2 operating expenses CHF -20.694 million. Q2 pretax profit CHF -21.189 million Q2 net income CHF -21.189 million Q2 EPS CHF -0.21
Recent news on AC Immune AG
See all newsAC Immune rises after Parkinson's drug shows promise in mid-stage trial
Brief: Ac Immune Reports Positive Safety & Immunogenicity At Week-100 In Part 1 Of Vacsyn Phase 2 Trial Of Aci-7104
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
U.S. STOCKS ON THE MOVE-Duke Energy, Sea, Cardinal Health